Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $27.77

Privia Health Group, Inc. (NASDAQ:PRVA) has been given a consensus rating of “Buy” by the thirteen brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $27.77.

PRVA has been the topic of several recent research reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $30.00 price objective on shares of Privia Health Group in a research note on Thursday, April 10th. Truist Financial lifted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Thursday, April 10th. JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 28th. Barclays boosted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 27th. Finally, JMP Securities reissued a “market outperform” rating and issued a $29.00 price target on shares of Privia Health Group in a report on Monday, April 28th.

Privia Health Group Trading Up 0.0%

Privia Health Group stock opened at $23.01 on Friday. The company’s 50-day moving average price is $23.42 and its two-hundred day moving average price is $22.81. The stock has a market cap of $2.81 billion, a price-to-earnings ratio of 230.12, a PEG ratio of 3.47 and a beta of 0.83. Privia Health Group has a 52 week low of $16.37 and a 52 week high of $26.09.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the company’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. This represents a 3.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Parth Mehrotra sold 15,100 shares of the company’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares in the company, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 51,579 shares of company stock worth $1,226,367 in the last 90 days. Corporate insiders own 10.70% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. CWM LLC increased its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares during the last quarter. First Horizon Advisors Inc. increased its stake in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares during the last quarter. Bessemer Group Inc. increased its stake in shares of Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after acquiring an additional 2,178 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after acquiring an additional 2,350 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in shares of Privia Health Group by 2,852.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after acquiring an additional 2,567 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.